STOCK TITAN

Delek US EVP sells 7,500 shares near $73

Delek US Holdings, Inc. (DK) reported that executive vice president for special projects Reuven Spiegel sold a total of 7,500 shares of common stock on September 1, 2026 in open-market or private transactions, at prices around the low $73 range per share.

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Delek US Holdings, Inc. (DK) reported that executive vice president for special projects Reuven Spiegel sold a total of 7,500 shares of common stock on September 1, 2026 in open-market or private transactions, at prices around the low $73 range per share. No Rule 10b5-1 trading plan is reported for these sales.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Spiegel Reuven
Role EVP, Special Projects
Sold 7,500 shs ($549K)
Type Security Shares Price Value
Sale Common Stock 7,000 $73.202 $512K
Sale Common Stock 500 $73.36 $37K
Holdings After Transaction: Common Stock — 28,935 shares (Direct)
Shares sold (first transaction) 7,000 shares Common stock sale on September 1, 2026 at $73.2020 per share
Shares sold (second transaction) 500 shares Common stock sale on September 1, 2026 at $73.3600 per share
Total shares sold 7,500 shares Aggregate of reported sales by Reuven Spiegel on September 1, 2026
Sale price per share (larger block) $73.2020 per share Price for 7,000 DK common shares sold September 1, 2026
Sale price per share (smaller block) $73.3600 per share Price for 500 DK common shares sold September 1, 2026
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is not marked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"describes the trades as a Sale in open market or private transaction"

FAQ

What insider transaction did Delek US Holdings (DK) disclose for September 1, 2026?

Delek US Holdings disclosed that EVP, Special Projects, Reuven Spiegel sold a total of 7,500 shares of common stock on September 1, 2026 in open-market or private transactions.

How many DK shares did Reuven Spiegel sell and at what prices?

Reuven Spiegel sold 7,000 shares at $73.2020 per share and an additional 500 shares at $73.3600 per share, for a combined total of 7,500 DK common shares sold.

Was the Delek US (DK) insider sale made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the September 1, 2026 sales by Reuven Spiegel were made pursuant to a Rule 10b5-1 trading plan.

What type of transaction were the DK shares sold in by Reuven Spiegel?

The Form 4 describes the September 1, 2026 trades as a “Sale in open market or private transaction” of Delek US Holdings common stock, indicating they were ordinary sale transactions rather than option exercises or gifts.

How many total DK shares were sold according to this Form 4 filing?

According to the summarized transactions, the reporting person sold 7,500 shares of Delek US Holdings common stock in total on September 1, 2026, all reported as direct ownership sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Spiegel Reuven

(Last)(First)(Middle)
310 SEVEN SPRINGS WAY
SUITE 500

(Street)
BRENTWOOD TENNESSEE 37027

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Special Projects
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026S7,000D$73.20229,435D
Common Stock09/01/2026S500D$73.3628,935D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Reuven Spiegel09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)